CPC, Part Of Dover, Launches Aseptic Micro-Connector For Use In Freeze Cassettes For Cell And Gene Therapy Processing To Enhance Cryopreservation And Minimize Material Loss During Shipment And Storage
Portfolio Pulse from Benzinga Newsdesk
CPC, a division of Dover Corporation, has launched an aseptic micro-connector designed for freeze cassettes used in cell and gene therapy processing. This innovation aims to improve cryopreservation and reduce material loss during shipment and storage.
September 11, 2024 | 8:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Dover Corporation's division, CPC, has introduced a new aseptic micro-connector for cell and gene therapy, potentially boosting its product offerings in the biotech sector.
The launch of the aseptic micro-connector by CPC, a division of Dover, is likely to enhance Dover's product portfolio in the biotech sector. This innovation addresses key issues in cell and gene therapy processing, potentially increasing demand for Dover's products and positively impacting its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80